CRVS - Corvus Pharmaceuticals EPS misses by $0.04 April, 29 2021 04:52 PM Corvus Pharmaceuticals Inc. Corvus Pharmaceuticals (CRVS): Q1 GAAP EPS of -$0.34 misses by $0.04.Cash, cash equivalents and marketable securities of $68.0MPress Release For further details see: Corvus Pharmaceuticals EPS misses by $0.04